I'm not sure if people here even read the entirety of the article. From the article: > We applied the AI co-scientist to assist with the prediction of drug repurposing opportunities and, with our partners, validated predictions through computational biology, expert clinician feedback, and in vitro experiments. > Notably, the AI co-scientist proposed novel repurposing candidates for acute myeloid leukemia (AML). Subse…
That a UPR inhibitor would inhibit viability of AML cell lines is not exactly a novel scientific hypothesis. They took a previously published inhibitor known to be active in other cell lines and tried it in a new one. It's a cool, undergrad-level experiment. I would be impressed if a sophomore in high school proposed it, but not a sophomore in college.
In this case they actually tested a drug probably because Google is paying for them to test whatever the AI came up with.